Lataa...
Methylated CpG dinucleotides in the 5-α reductase 2 gene may explain finasteride resistance in benign prostatic enlargement patients
The inhibition of 5-α reductase type 2 (SRD5A2) by finasteride is commonly used for the management of urinary obstruction resulting from benign prostatic enlargement (BPE). Certain BPE patients showing no SRD5A2 protein expression are resistant to finasteride therapy. Our previous work showed that m...
Tallennettuna:
| Julkaisussa: | Asian J Androl |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wolters Kluwer - Medknow
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8152415/ https://ncbi.nlm.nih.gov/pubmed/33243958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/aja.aja_63_20 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|